CAREYOU Co., Ltd. has unveiled an innovative biometric authentication system utilizing palm vein recognition technology in its AI-driven service, CareCall. This revolutionary advancement aims to enhance safety and ease of use for seniors with contactless verification methods, creating a secure digital care ecosystem.
On October 30, 2025, in Seoul, South Korea, the company highlighted how this cutting-edge system leverages "Vein-ID" technology to identify users accurately without the need for fingerprints or passwords. The non-contact nature of this method addresses common challenges for older adults, such as hand tremors or diminished memory, ensuring hygienic and efficient authentication even in high-risk healthcare settings.
Key features of this advancement include:
- Contactless Authentication: Users can verify their identities simply by scanning their palms, promoting safety and convenience.
- Wide Accessibility: CareCall will integrate this system into both mobile applications and tablet devices, providing seamless access to crucial functions such as health monitoring and family communication.
- Launch Timeline: The palm recognition system will debut in November 2025 at the Seoul Digital Experience Zone, followed by broader implementation in senior welfare centers and nursing homes.
This technology is particularly beneficial in reducing infection risks for vulnerable populations, especially amid ongoing health concerns like COVID-19. CEO Junyoung Shin emphasized that this biometric system represents a pivotal move towards a more inclusive digital care model where seniors are treated with respect and safety.
CAREYOU’s initiative not only reinforces its commitment to advancing senior care technology but also positions the company as a leader in the AgeTech industry globally. Future plans also include incorporating palm vein data into broader health monitoring solutions, reinforcing the company’s vision of a “Smart Senior Care Platform” that merges AI and biotechnologies.
For more details, visit CAREYOU’s official website.
